233 related articles for article (PubMed ID: 31924156)
21. Current status and future development of antitubercular chemotherapy.
Kremer LS; Besra GS
Expert Opin Investig Drugs; 2002 Aug; 11(8):1033-49. PubMed ID: 12150700
[TBL] [Abstract][Full Text] [Related]
22. Mechanistic investigation of resistance via drug-inactivating enzymes in Mycobacterium tuberculosis.
Kashyap A; Singh PK; Silakari O
Drug Metab Rev; 2018 Nov; 50(4):448-465. PubMed ID: 30343607
[TBL] [Abstract][Full Text] [Related]
23. Targeting iron acquisition by Mycobacterium tuberculosis.
Monfeli RR; Beeson C
Infect Disord Drug Targets; 2007 Sep; 7(3):213-20. PubMed ID: 17897057
[TBL] [Abstract][Full Text] [Related]
24. Worldwide emergence of extensively drug-resistant tuberculosis.
Shah NS; Wright A; Bai GH; Barrera L; Boulahbal F; Martín-Casabona N; Drobniewski F; Gilpin C; Havelková M; Lepe R; Lumb R; Metchock B; Portaels F; Rodrigues MF; Rüsch-Gerdes S; Van Deun A; Vincent V; Laserson K; Wells C; Cegielski JP
Emerg Infect Dis; 2007 Mar; 13(3):380-7. PubMed ID: 17552090
[TBL] [Abstract][Full Text] [Related]
25. Advanced cellular systems to study tuberculosis treatment.
Bielecka MK; Elkington P
Curr Opin Pharmacol; 2018 Oct; 42():16-21. PubMed ID: 29990957
[TBL] [Abstract][Full Text] [Related]
26. Revolutionizing Tuberculosis Treatment: Uncovering New Drugs and Breakthrough Inhibitors to Combat Drug-Resistant
Verma A; Naik B; Kumar V; Mishra S; Choudhary M; Khan JM; Gupta AK; Pandey P; Rustagi S; Kakati B; Gupta S
ACS Infect Dis; 2023 Dec; 9(12):2369-2385. PubMed ID: 37944023
[TBL] [Abstract][Full Text] [Related]
27. Drug resistance mechanisms and novel drug targets for tuberculosis therapy.
Islam MM; Hameed HMA; Mugweru J; Chhotaray C; Wang C; Tan Y; Liu J; Li X; Tan S; Ojima I; Yew WW; Nuermberger E; Lamichhane G; Zhang T
J Genet Genomics; 2017 Jan; 44(1):21-37. PubMed ID: 28117224
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and bioactivity of antitubercular peptides and peptidomimetics: an update.
De Leon Rodriguez LM; Kaur H; Brimble MA
Org Biomol Chem; 2016 Jan; 14(4):1177-87. PubMed ID: 26645944
[TBL] [Abstract][Full Text] [Related]
29. Peptide deformylase--a promising therapeutic target for tuberculosis and antibacterial drug discovery.
Sharma A; Khuller GK; Sharma S
Expert Opin Ther Targets; 2009 Jul; 13(7):753-65. PubMed ID: 19530983
[TBL] [Abstract][Full Text] [Related]
30. Fighting an old disease with modern tools: characteristics and molecular detection methods of drug-resistant Mycobacterium tuberculosis.
Engström A
Infect Dis (Lond); 2016; 48(1):1-17. PubMed ID: 26167849
[TBL] [Abstract][Full Text] [Related]
31. Utilisation of the Prestwick Chemical Library to identify drugs that inhibit the growth of mycobacteria.
Kanvatirth P; Jeeves RE; Bacon J; Besra GS; Alderwick LJ
PLoS One; 2019; 14(3):e0213713. PubMed ID: 30861059
[TBL] [Abstract][Full Text] [Related]
32. Recent advances in the research of heterocyclic compounds as antitubercular agents.
Yan M; Ma S
ChemMedChem; 2012 Dec; 7(12):2063-75. PubMed ID: 23042656
[TBL] [Abstract][Full Text] [Related]
33. Comparison of
Zong Z; Jing W; Shi J; Wen S; Zhang T; Huo F; Shang Y; Liang Q; Huang H; Pang Y
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844043
[TBL] [Abstract][Full Text] [Related]
34. Tuberculosis chemotherapy: the influence of bacillary stress and damage response pathways on drug efficacy.
Warner DF; Mizrahi V
Clin Microbiol Rev; 2006 Jul; 19(3):558-70. PubMed ID: 16847086
[TBL] [Abstract][Full Text] [Related]
35. [Management of multidrug-resistant tuberculosis].
Tritar F; Daghfous H; Ben Saad S; Slim-Saidi L
Rev Pneumol Clin; 2015; 71(2-3):130-9. PubMed ID: 25153927
[TBL] [Abstract][Full Text] [Related]
36. DFT based QSAR/QSPR models in the development of novel anti-tuberculosis drugs targeting Mycobacterium tuberculosis.
Rajkhowa S; Deka RC
Curr Pharm Des; 2014; 20(27):4455-73. PubMed ID: 24245759
[TBL] [Abstract][Full Text] [Related]
37. Drug resistance mechanisms and drug susceptibility testing for tuberculosis.
Miotto P; Zhang Y; Cirillo DM; Yam WC
Respirology; 2018 Dec; 23(12):1098-1113. PubMed ID: 30189463
[TBL] [Abstract][Full Text] [Related]
38. Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug Targets.
Alsayed SSR; Gunosewoyo H
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982277
[No Abstract] [Full Text] [Related]
39. Clofazimine: A useful antibiotic for drug-resistant tuberculosis.
Mirnejad R; Asadi A; Khoshnood S; Mirzaei H; Heidary M; Fattorini L; Ghodousi A; Darban-Sarokhalil D
Biomed Pharmacother; 2018 Sep; 105():1353-1359. PubMed ID: 30021373
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
